Zymeworks Inc. (ZYME)

USD 12.74

(-4.71%)

Total Debt Summary of Zymeworks Inc.

Zymeworks Inc.'s latest annual total debt in 2023 was 26.72 Million USD , down -4.95% from previous year.
Zymeworks Inc.'s latest quarterly total debt in 2024 Q3 was 20.21 Billion USD , up 0.93% from previous quarter.
Zymeworks Inc. reported annual total debt of 28.11 Million USD in 2022, down -13.05% from previous year.
Zymeworks Inc. reported annual total debt of 32.33 Million CAD in 2021, up 274.05% from previous year.
Zymeworks Inc. reported quarterly total debt of 20.06 Million USD for 2024 Q2, down -20.45% from previous quarter.
Zymeworks Inc. reported quarterly total debt of 20.21 Billion USD for 2024 Q3, up 0.93% from previous quarter.

Annual Total Debt Chart of Zymeworks Inc. (2023 - 2014)

Historical Annual Total Debt of Zymeworks Inc. (2023 - 2014)

Year	Total Debt	Total Debt Growth
2023	26.72 Million USD	-4.95%
2022	28.11 Million USD	-13.05%
2021	32.33 Million CAD	274.05%
2020	8.64 Million USD	24.79%
2019	6.92 Million USD	12052.63%
2018	57 Thousand USD	-8.06%
2017	62 Thousand USD	-98.6%
2016	4.42 Million USD	73650.0%
2015	6000.00 USD	0.0%
2014	- USD	0.0%

Year	Total Debt	Total Debt Growth
2024 Q1	25.22 Million USD	-5.61%
2024 Q2	20.06 Million USD	-20.45%
2024 Q3	20.21 Billion USD	0.93%
2023 Q1	27.34 Million USD	-2.75%
2023 FY	26.72 Million USD	-4.95%
2023 Q4	26.72 Million USD	1.8%
2023 Q3	26.24 Million USD	-3.69%
2023 Q2	27.25 Million USD	-0.31%
2022 Q4	28.11 Million USD	-6.58%
2022 FY	28.11 Million USD	-13.05%
2022 Q3	30.09 Million USD	-5.98%
2022 Q1	31.84 Million USD	-1.52%
2022 Q2	32 Million USD	0.53%
2021 FY	32.33 Million CAD	274.05%
2021 Q4	32.33 Million CAD	7.09%
2021 Q3	30.19 Million USD	-5.18%
2021 Q1	8.42 Million USD	-2.58%
2021 Q2	31.84 Million USD	278.14%
2020 Q2	8.57 Million USD	-5.8%
2020 Q4	8.64 Million USD	8.29%
2020 Q1	9.1 Million USD	31.47%
2020 Q3	7.98 Million USD	-6.96%
2020 FY	8.64 Million USD	24.79%
2019 Q4	6.92 Million USD	1.7%
2019 Q3	6.81 Million USD	-13.65%
2019 Q2	7.88 Million USD	-2.79%
2019 Q1	8.11 Million USD	14135.09%
2019 FY	6.92 Million USD	12052.63%
2018 Q1	67 Thousand USD	8.06%
2018 Q2	65 Thousand USD	-2.99%
2018 Q3	62 Thousand USD	-4.62%
2018 Q4	57 Thousand USD	-8.06%
2018 FY	57 Thousand USD	-8.06%
2017 FY	62 Thousand USD	-98.6%
2017 Q4	62 Thousand USD	520.0%
2017 Q3	10 Thousand USD	0.0%
2017 Q2	10 Thousand USD	-99.78%
2017 Q1	4.52 Million USD	2.26%
2016 Q3	3.73 Million USD	0.0%
2016 Q1	- USD	0.0%
2016 Q4	4.42 Million USD	18.57%
2016 FY	4.42 Million USD	73650.0%
2015 Q4	- USD	0.0%
2015 FY	6000.00 USD	0.0%
2014 FY	- USD	0.0%

Peer Total Debt Comparison of Zymeworks Inc.

Name	Total Debt	Total Debt Difference
ADC Therapeutics SA	124.37 Million USD	78.515%
Alto Neuroscience, Inc.	151.46 Million USD	82.357%
Annovis Bio, Inc.	- USD	-Infinity%
Biohaven Pharmaceutical Holding Company Ltd.	30.87 Million USD	13.457%
Ginkgo Bioworks Holdings, Inc.	241.76 Million USD	88.947%
Nuvation Bio Inc.	4 Million USD	-566.883%
Nuvation Bio Inc.	4 Million USD	-566.883%
Arcus Biosciences, Inc.	11 Million USD	-142.927%
Theriva Biologics, Inc.	2.15 Million USD	-1140.576%